+ Site Statistics
+ Search Articles
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ PDF Full Text
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Translate
+ Recently Requested

Long-term Outcome in a Series of Jejunoileal Bypass Patients

Long-term Outcome in a Series of Jejunoileal Bypass Patients

Obesity Surgery 3(3): 247-252

In 65 jejunolleal (JI) bypasses done from 1973-1979, there were nine Scott and 56 Payne (with Y-shaped anastomosis). Preoperative excess body weight (EBW) translated to the 1983 Metropolitan Tables was 112 +/- 30%. Eight patients are lost to follow-up. We reversed seven patients for renal stones (12%) accompanied by a vertical banded gastroplasty (VBG) and one because she demanded a VBG. Five patients were reversed by surgeons elsewhere for minor problems (three with an accompanying gastric reduction operation), and all five regained and requested a JI bypass again, which we now refused to undertake. This leaves 44 JI bypass patients being followed: loss of EBW is 71 +/- 22% at 12-18 years. The eight reversed by us accompanied by a VBG regained some weight (loss of EBW from initial weight is 56 +/- 18%). Liver biopsies were done for 5 years in 31 patients, and showed improvement by 36 months. Patients took predigested collagen capsules plus high protein and multivitamins. Injections of B12 are indicated in 18 patients, given every 3 months. Liver dysfunction has not occurred in the long-term. Low serum carotene levels persist. Migratory arthraigias were controlled by oral metronidazole and did not occur after the fifth year. Oxalate crystals remain on urinalysis. Potassium and magnesium replacement is not required now, and a mean of 2.5 stools per day is not a problem, with infrequent diarrhea after greasy foods. Metronidazole is continued in 33 patients to prevent foul flatus. One patient developed a brain tumor, one myxedema, and one primary hyperparathyroidism, thought to be complications of the bypass until diagnosed. Most patients appear to be doing well.

(PDF emailed within 0-6 h: $19.90)

Accession: 046567357

Download citation: RISBibTeXText

PMID: 10757927

DOI: 10.1381/096089293765559250

Related references

Long-term outcome after jejunoileal bypass for morbid obesity. International Journal of Obesity 8(4): 319-325, 1984

Jejunoileal bypass for morbid obesity. Report of a series with long-term results. Acta Chirurgica Scandinavica 155(8): 401-407, 1989

Long-term follow-up of jejunoileal bypass patients. American Journal of Clinical Nutrition 33(2 Suppl): 472-475, 1980

Long-term Follow-up of Jejunoileal Bypass Patients with Preoperative Cirrhosis of the Liver. Obesity Surgery 4(1): 37-39, 1994

Long term follow up of patients who underwent jejunoileal bypass for morbid obesity. European Journal of Surgery 164(4): 281-286, 1998

Improved long-term outcome for patients with jejunoileal apple peel atresia. Journal of Pediatric Surgery 32(9): 1307-1309, 1997

Long-term morbidity of jejunoileal bypass. American Surgeon 43(6): 389-391, 1977

Jejunoileal bypass. Long-term results. Annals of Surgery 192(1): 38-43, 1980

Long-term results of jejunoileal bypass in the young. American Surgeon 50(11): 589-593, 1984

Long-term consequences after jejunoileal bypass for morbid obesity. Digestive Diseases & Sciences 43(11): 2493-2499, 1998

Favorable Long-term Results with the End-to-Side Jejunoileal Bypass. Obesity Surgery 5(4): 357-363, 1995

Long-term results (up to 16.5 years) of mitral balloon valvuloplasty in a series of 518 patients and predictors of long-term outcome. Journal of Interventional Cardiology 20(1): 66-72, 2007

Long term results of treatment of obesity by means of the jejunoileal bypass. Cahiers de Nutrition et de Dietetique 20(4): 251, 1985

Long term follow up study of liver biopsies after jejunoileal ji bypass. Laboratory Investigation 58(1): 54A, 1988